Farrell Breege A, EVP, Chief Investment Officer, sold 7,500 shares of the Unum Group (NYSE:UNM) in an exchange that happened on July 31st, 2018. The stock was sold at an average price of $40.66 per share, amounting to a transaction worth $304,938. The sale was made public in a document filed with the SEC. Additionally, EVP, President & CEO, Unum US Simonds Michael Q sold 5,000 shares of this stock in a transaction that took place on April 30th, 2018. The stock was sold at an average price of $48.94 per share, for a total exchange amounting to $244,700. After the transaction, the EVP, President & CEO, Unum US Simonds Michael Q currently holds 72,272 shares of the company’s stock, which is worth approximately $2749950.
With this stock price’s latest movement, it is now -35.21% away from its 1-year high and 14.37% higher than its 1-year low price. In the past seven days, the stock price volatility for Unum Group was 2.29%, whereas its volatility in the past 30 days has been 3.47%. This public company’s stock also has a beta score of 1.31. When the beta value is less/more than 1, it can imply that the stock is less/more volatile than the wider stock market – a metric that traders will surely be keeping tabs on.
Unum Group (NYSE:UNM) most recently published its quarterly earnings results. The firm posted $1.37 earnings per share (EPS) for the three-month period, surpassing analysts’ consensus estimate of $1.29 by $0.08. The publicly-traded organization reported revenue of $2,921.10 million for the quarter, compared to the average analyst forecast calling for $2,893.11 million, which was surpassing the analyst consensus estimate.
Shares of Unum Group (UNM) surged 2.09%, amounting to a gain of $0.77999999999999 per share, to finish the regular trading session at $38.05 on Wednesday 11/07/2018. After beginning the session at $37.51, shares of Unum Group reached as high as $38.265 during the day, while hitting a 1-day low of $37.31. Trade volume reached 2,144,248 shares against this stock’s average daily volume of 2.33M shares, with a total float of 217.79M. As a consequence of the price increase, Unum Group now has a current market value of 8.33B.
Sabra Health Care REIT, Inc. (NASDAQ:SBRA) added 1.07% to its trading price by the close of the most recent session, jumping from its previous closing price of $21.46 to $21.69. This stock decreased in value by 0.18% during the last 7-day period, and experienced a gain of -4.45% over the past 30-day period. In the past three months, this stock’s price lost by -2.69% , and added 7.75% to its price during the last six months of trading. SBRA demonstrated a yearly price gain of 11.92% , while its year-to-date (YTD) price performance has been up 15.56% . This stock’s price changed by +15.37% compared to its 90-day low, and moved down -8.98% comparing to its 90-day high price.
Have a quick look on short, medium and long-term indicators. According to the Composite Indicator, Trendspotter rated the SBRA stock as “Sell”. In the short-term, Sabra Health Care REIT, Inc. (SBRA) has a 20-day average volume of 1,912,325 shares and short-term indicators sets the SBRA stock as “ 60% Sell ” on average basis. In the medium-term, SBRA stock has a 50-Day average volume of 1,536,386 shares and medium-term indicators gave the average rating of “ 75% Sell ”, while in the long-term period the FB stock has a 100-Day average volume of 1,402,797 shares. On average, long-term indicators rated the stock as “33% Sell ”. The overall picture from all short, medium and long-term indicators sets the SBRA stock as “64% Sell ” on average basis.
Recently, multiple brokerages have sent out reports on SBRA. Raymond James, for example, Upgrade its rating on shares of Sabra Health Care REIT, Inc. from “Mkt Perform ” to a “ Outperform”according to a research note from Monday May 21st, 2018. while giving the stock a “ Neutral” from “Underperform ” rating, as stated in a research report from Monday, March 26th, 2018. Stifel, on the other hand, Reiterated a “Hold” rating on this stock, while posting a $21 price target on shares of this company’s stock in a research note dated Thursday, February 22nd, 2018.
In other news related to Sabra Health Care REIT, Inc. stock, 0.00% shares of SBRA held by institutions. The total number of institutions who held the SBRA shares was 458, according to most recent SEC filling. During the past quarter, total 178,966,282 shares held by institutions with the net change of 5,601,981 shares. In the meantime, 16 new institutions bought the shares of Sabra Health Care REIT, Inc. for the first time and 14 institutions sold all their holdings in the company’s common stock. 75 institutions increased their investment in the SBRA stock and 65 institutions decreased their investment in the Sabra Health Care REIT, Inc. (SBRA)’s stock during the last quarter.